Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3335507 | Transfusion and Apheresis Science | 2012 | 7 Pages |
Abstract
Extracorporeal photopheresis (ECP) has been used for treatment of steroid-refractory graft versus host disease (GVHD) with encouraging results. Although its exact mechanism of action is not fully understood, photoapheresed cells seem to induce a selective immune response directed against alloreactive T cell populations without causing generalized immunosuppression. Current pediatric experience with ECP for GVHD is available in the form of a few retrospective small studies concerning children with steroid refractory GVHD. Reviewing these data we conclude that ECP is a safe procedure, well tolerated even in low-weight pediatric patients, which warrants further evaluation in well-designed, prospective, controlled studies.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Evgenios Goussetis, Ioanna Varela, Panagiotis Tsirigotis,